RegionWhat is GAMP 5?
GAMP 5 (Good Automated Manufacturing Practice) is a set of guidelines developed by the International Society for Pharmaceutical Engineering (ISPE) to ensure the quality and compliance of computerized systems used in the pharmaceutical industry. It provides a framework for the validation and qualification of automated systems throughout their lifecycle.
What are the key Principles of GAMP 5?
- Risk Management: GAMP 5 emphasizes a science-based risk management approach to system validation and qualification. It encourages organizations to identify and assess potential risks associated with automated systems.
- Lifecycle Approach: The framework promotes a lifecycle approach to system development and maintenance, recognizing that systems evolve over time and advocating for validation activities to be conducted throughout the system’s lifecycle.
- Supplier and Internal Audits: GAMP 5 stresses the importance of auditing suppliers and internal processes to ensure compliance and quality.
- Documentation and Traceability: The guidelines emphasize the need for comprehensive documentation and traceability throughout the system’s lifecycle.
- Change Management: GAMP 5 encourages organizations to have change management processes and robust procedures in place to ensure that changes do not compromise product quality or patient safety.
What are the benefits of GAMP 5?
- Ensures regulatory compliance with various authorities like the FDA and EMA
- Maintains data integrity and consistently produces high-quality products
- Mitigates risks associated with automated systems
- Improves efficiency in system development, implementation, and maintenance
How is GAMP 5 related with 21 CFR Part 11 and EU Annex 11?
GAMP 5 provides a methodology for implementing the requirements of 21 CFR Part 11 (US FDA) and EU Annex 11, which define the criteria for electronic records and electronic signatures.
